Boston scientific announces agreement to acquire sonivie ltd.

Acquisition to expand interventional cardiology therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension marlborough, mass. , march 3, 2025 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced it has entered into a definitive agreement to acquire sonivie ltd.
BSX Ratings Summary
BSX Quant Ranking